Michael L. Maitland, MD, PhD

Assistant Professor of Medicine

Medical oncologist Dr. Michael Maitland focuses on caring for patients with lung cancer, esophageal cancer, mesothelioma, and advanced solid tumors.

He is a broadly trained physician-scientist who leads a research program in translational medicine and cancer therapeutics. The goal of translational medicine is to improve patient care by quickly and effectively applying recent advances in laboratory research. The program currently concentrates on angiogenesis inhibitors, a class of drugs that treat tumors by modifying their blood supply.

Dr. Maitland applies his expertise in human genetics, clinical pharmacology, molecular biology, and clinical investigation to develop new methods to tailor the selection and dosing of medical treatment to each patient's specific circumstances. Personalized treatment aims to make cancer care more effective, but with fewer side effects and complications.

Practice Location

Center for Advanced Medicine
5758 S. Maryland Avenue
Chicago, IL 60637

University of Chicago Medical Center
5841 S. Maryland Avenue
Chicago, IL 60637

Year Started Practice

2006

Board Certifications

Internal Medicine
Oncology

Medical School

Albert Einstein College of Medicine, Bronx, NY

Internship and Residency

New York Presbyterian Hospital-Weill/Cornell Medical Center, New York

Fellowship

Memorial Sloan-Kettering Cancer Center, New York
University of Chicago Medical Center

Memberships

American Association for Cancer Research
American Society for Clinical Pharmacology and Therapeutics
American Society of Clinical Oncology
American Society of Human Genetics